Cognition Therapeutics In...

AI Score

0

Unlock

0.46
0.00 (0.37%)
At close: Feb 28, 2025, 3:59 PM
0.45
-2.28%
Pre-market: Mar 03, 2025, 05:09 AM EST

Cognition Therapeutics Income Statement

Year FY23 FY22 FY21 FY20 FY19
Revenue n/a n/a n/a n/a n/a
Cost of Revenue 252K 235K 93K 98K 81K
Gross Profit -252K -235K -93K -98K -81K
Operating Income -50.72M -43.55M -28.6M -17.41M -17.83M
Interest Income 27K 22.22M 17.45M 10.86M 13.16M
Pretax Income -25.79M -21.4M -11.72M -7.84M -4.84M
Net Income -25.79M 757K -10.29M -10.07M -6.95M
Selling & General & Admin 13.53M 13.23M 10.03M 4.52M 3.45M
Research & Development 37.2M 30.32M 18.57M 12.89M 14.38M
Other Expenses n/a -22.22M -17.45M -10.86M -13.16M
Operating Expenses 50.72M 21.33M 11.15M 6.55M 4.67M
Interest Expense n/a 28K 893K 1.75M 1.02M
Selling & Marketing Expenses n/a n/a n/a n/a n/a
Cost & Expenses 50.72M 21.33M 11.15M 6.55M 4.67M
Income Tax n/a -22.15M -1.43M 2.23M 2.11M
Shares Outstanding (Basic) 29.99M 28.99M 22.23M 21.94M 21.94M
Shares Outstanding (Diluted) 30.03M 28.99M 22.23M 21.94M 21.94M
EPS (Basic) -0.86 0.03 -0.46 -0.46 -0.32
EPS (Diluted) -0.86 0.03 -0.46 -0.46 -0.32
EBITDA -25.51M -21.13M -13.38M -5.99M -3.5M
Depreciation & Amortization 252K 235K 93K 98K 81K